Omary M B, Trowbridge I S, Minowada J
Nature. 1980 Aug 28;286(5776):888-91. doi: 10.1038/286888a0.
We report here the identification of human cell-surface glycoprotein with unusual and interesting properties. We initially detected this glycoprotein on the surface of cultured human haematopoietic cell lines by means of a monoclonal antibody. Although it is expressed on all cultured human haematopoietic cell lines tested, including the inducible promyelocytic tumour cell line HL-60 (ref. 1), it is not present in readily detectable amounts on most normal or leukaemic human haematopoietic cells. HL-60 cells, on exposure in vitro to appropriate chemical inducers, undergo morphological and functional differentiation along the granulocytic pathway or into macrophage-like cells. One consequence of in vitro induction in the specific loss of the glycoprotein from the surface of HL-60 cells. The molecule does not, however, seem to be a highly tissue-specific differentiation antigen because it is also found on human tumour cell lines derived from non-haematopoietic tissues. Rather, its expression seems to be related to cell proliferation. Preliminary chemical characterization suggests that the glycoprotein maybe identical to the abnormal glycoprotein previously reported by Bramwell and Harris to be associated with malignancy.
我们在此报告一种具有异常且有趣特性的人类细胞表面糖蛋白的鉴定情况。我们最初通过单克隆抗体在培养的人类造血细胞系表面检测到了这种糖蛋白。尽管它在所测试的所有培养人类造血细胞系中都有表达,包括可诱导的早幼粒细胞肿瘤细胞系HL - 60(参考文献1),但在大多数正常或白血病人类造血细胞中却不存在易于检测到的量。HL - 60细胞在体外暴露于合适的化学诱导剂时,会沿着粒细胞途径或分化为巨噬细胞样细胞,发生形态和功能上的分化。体外诱导的一个结果是HL - 60细胞表面糖蛋白的特异性丢失。然而,该分子似乎并非高度组织特异性的分化抗原,因为在源自非造血组织的人类肿瘤细胞系中也能发现它。相反,其表达似乎与细胞增殖有关。初步的化学特征表明,这种糖蛋白可能与Bramwell和Harris先前报道的与恶性肿瘤相关的异常糖蛋白相同。